• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Eli Lilly and Company (LLY)

    -NYSE
    72.40 Down 0.05(0.07%) Dec 19, 4:03PM EST
    |After Hours : 72.40 Down 0.00 (0.00%) Dec 19, 6:51PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Eli Lilly and Company
    Lilly Corporate Center
    Indianapolis, IN 46285
    United States - Map
    Phone: 317-276-2000
    Website: http://www.lilly.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:37,925

    Business Summary 

    Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health Products. The company offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men at high risk of fracture; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency, as well as provides anti-infectives. Its neuroscience products treat major depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia, acute mixed or manic episodes associated with bipolar I disorder, and bipolar maintenance; attention-deficit hyperactivity disorder; depressive disorder, obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and brain imaging of beta-amyloid neuritic plaques. The company’s oncology products treat pancreatic, metastatic breast, non-small cell lung, ovarian, bladder, colorectal, and head and neck cancers, as well as malignant pleural mesothelioma; and cardiovascular products are used to treat erectile dysfunction and benign prostatic hyperplasia, and pulmonary arterial hypertension, as well as to reduce thrombotic cardiovascular events and as adjunct to percutaneous coronary intervention. In addition, it provides animal health products, such as cattle feed additives; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; leanness and performance enhancers for swine and cattle; protein supplements to enhance milk productivity in dairy cows; anticoccidial agents; and products that prevent flea infestations on dogs, kills fleas, prevent heartworm disease, and control intestinal parasite infections. The company distributes its products through independent wholesale distributors and directly to pharmacies. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Eli Lilly and Company

    Corporate Governance 
    Eli Lilly and Company’s ISS Governance QuickScore as of Dec 1, 2014 is 9. The pillar scores are Audit: 10; Board: 2; Shareholder Rights: 9; Compensation: 7.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Dr. John C. Lechleiter Ph.D., 60
    Chairman, Chief Exec. Officer and Pres
    4.47M0.00
    Mr. Derica W. Rice , 49
    Chief Financial Officer, Exec. VP of Global Services, Member of Operations Committee and Member of Policy & Strategy Committee
    2.33M0.00
    Dr. Jan M. Lundberg Ph.D., 60
    Exec. VP of Science & Technology and Pres of Lilly Research Laboratories
    2.30M0.00
    Mr. Michael J. Harrington , 51
    Sr. VP and Gen. Counsel
    1.60M0.00
    Mr. Enrique A. Conterno , 47
    Sr. VP and Pres of Lilly Diabetes
    1.42M0.00
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders